Mithra Pharmaceuticals SA
F:1TM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mithra Pharmaceuticals SA
F:1TM
|
BE |
|
E
|
Enanta Pharmaceuticals Inc
F:9EP
|
US |
|
V
|
Volatus Capital Corp
F:VOY0
|
CA |
|
C
|
Cresco Labs Inc
CNSX:CL
|
US |
|
D
|
Diguang International Development Co Ltd
OTC:DGNG
|
CN |
|
Metrospaces Inc
OTC:MSPC
|
US |
|
M
|
MCS Steel PCL
SET:MCS
|
TH |
|
L
|
Lentex SA
F:0KM
|
PL |
|
R
|
Reply SpA
F:REJA
|
IT |
|
A
|
Aura Minerals Inc
F:A531
|
US |
|
M
|
Middle Island Resources Ltd
F:M83
|
AU |
|
K
|
K&S AG
DUS:SDF
|
DE |
Bankruptcy Probability
Mithra Pharmaceuticals SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Mithra Pharmaceuticals SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BE |
|
Mithra Pharmaceuticals SA
XBRU:MITRA
|
14.9m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
627B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
335.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
232.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
179.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
263.6B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Mithra Pharmaceuticals SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Mithra Pharmaceuticals SA has total debt of 179.2m EUR. This includes both short-term (0 EUR) and long-term (179.2m EUR) debt.
You can find a full breakdown on its Balance Sheet.
